Adam J. Simon, PhD, is founder and CEO of Cerora, a healthcare information technology company focused on the transition from subjective clinical impression to neuro biosensor information in brain health assessment. He is an accomplished physicist (U. Chicago) with over 20 years of drug development, biomarker and business start-up experience. Dr. Simon worked at Merck Research Laboratories for 13 years where he focused on drug discovery and pre-clinical neuroscience biomarkers where he was awarded the Merck Blue Sky Innovation Award (2008). Recognized internationally for his novel Alzheimer’s disease (AD) drug and biomarker research, he co-organized an AD biomarkers conference and regularly volunteers time for the Alzheimer’s Association and CAMD. Since 2009, he has been passionately developing biosensor based brain health assessment technology, focusing first on mild traumatic brain injury and concussion. Cerora was the first in the world (that we know of) to demonstrate a working medical Google Glassware (June 18, 2013 at Kaiser Permanente MeetUp). The Company is leading the way towards developing objective, easy to use, portable technology for brain health assessment.
Adam Simon
